Davidl Epstein News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Rockville, Md.—The Association for Research in Vision and Ophthalmology (ARVO) Foundation announced today the 2024 recipients of the Dr. David L. Epstein Awar

Association for Research in Vision and Ophthalmology (ARVO)News, press releases, and expert sources for journalists in science, medicine & business

As policymakers look ahead, they must find a way to balance the need for inclusive resilience with the imperative for meaningful reform.

Markets Needham analyst Serge Belanger maintained a Buy rating on Aerie Pharma (AERI – Research Report) today and set a price target of $26.00. The company’s shares closed last Tuesday at $17.66. According to TipRanks.com, Belanger is a 4-star analyst with an average return of 8.8% and a 49.5% success rate. Belanger covers the Healthcare sector, focusing on stocks such as Amphastar Pharmaceuticals, KalVista Pharmaceuticals, and Collegium Pharmaceutical. Aerie Pharma has an analyst consensus of Strong Buy, with a price target consensus of $27.25, implying a 47.6% upside from current level...

Credit: Thomas Johnson and Johns Hopkins Medicine In experiments in mouse tissues and human cells, Johns Hopkins Medicine researchers say they have found that removing a membrane that lines the back of the eye may improve the success rate for regrowing nerve cells damaged by blinding diseases. The findings are specifically aimed at discovering new ways to reverse vision loss caused by glaucoma and other diseases that affect the optic nerve, the information highway from the eye to the brain. "The idea of restoring vision to someone who has lost it from optic nerve disease has been considered s...